Skip to main content
. 2020 Aug 7;12(8):744. doi: 10.3390/pharmaceutics12080744

Figure 12.

Figure 12

Comparative assessment of the in vitro release profiles of captopril from the orally disintegrating tablets containing the CAP-β-CD inclusion complex in simulated saliva (red) and 0.01 N (green) HCl, respectively.